When KCl is infused too rapidly, serum potassium spikes faster than the body can redistribute or excrete it. This causes acute hyperkalemia, which has a predictable and potentially fatal progression of effects on the heart.
Rapid IV infusion can drive serum potassium through all these stages within
minutes, before any intervention is possible. The
FDA labeling for concentrated KCl explicitly warns that "administration of concentrated potassium solutions can cause cardiac conduction disorders (including complete heart block) and other cardiac arrhythmias at any time during infusion."
Concentrated KCl ampoules have been involved in numerous fatal medication errors worldwide (ampoules of concentrated KCl look similar to saline). The
ISMP (Institute for Safe Medication Practices) and most hospital systems require: